Investigations into a TNF inhibitor to limit complications following complex surgery

Phase 1

• Conditions: Vascular surgery; Surgery - Other surgery

• Registration Number: ACTRN12608000001392
• Lead Sponsor: St.Vincent's Health Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-01-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Scheduled for elective vascular surgery

Exclusion Criteria

concurrent use of Interleukin-1 antagonist, septic arthritis in last 12 months, any infection, pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TNF levels in blood tests[Blood tests will be taken at 1,2 and 4 hours following anaesthetic induction]

Secondary Outcome Measures

Name	Time	Method
Adverse events[Total number of adverse events will be reviewed at 90 days]